SEC Form 4 · accession 0001179110-16-023126
Blueprint Medicines Corp · BPMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lynn Seely
Director
Period of report
Apr 14, 2016
Accepted (ET)
Apr 15, 2016 · 6:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597264
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $19.08 | Apr 14, 2016 | A | 21,818 | A | — | Apr 14, 2026 | Common Stock | 21,818 | 21,818 | D |
Explanation of responses
- F1This option vests with respect to 1/36th of the shares underlying the option on May 14, 2016 and as to an additional 1/36th of the shares underlying the option each month thereafter.